Preprint · OA
via OpenAlex
[The role of alpha-synuclein in Parkinson's disease].
Ildikó Miklya, N Pencz, Florencia Hafenscher, P Goltl
PubMed · 2014 · ▲ 9 citations
Abstract
α-synuclein, a small protein (140 amino acids) encoded by the SNCA gene is the best known isoform of the synuclein protein family. Though its physiological role is still not fully clarified, there is growing experimental evidence for a causal role of α-synuclein in the so-called conformational-neurodegenerative diseases. Conformational changes in the structure of the native soluble protein form insoluble neurotoxic aggregates and finally contribute to the formation of inclusion Lewy-bodies and Lewy-neurites. Neurodegeneration first hits the olfactory system, the peripheral autonomic nervous system, the enteric nervous system and the dorsal vagal motoneurons. The middle stage of the disease hits the dopaminergic neurons of the substantia nigra; and the neocortex is affected only in the late stage of the disease. This precise order of neurodegeneration is not always valid, but increases the likelihood that Lewy-bodies and neurodegenaration spread to intact areas in a prion-like way. Prions are infectious proteins which do not contain nucleic acids and cause diseases because they form toxic aggregates and filaments by misfolding in a β-sheet-rich conformation. The misfolded protein behaves like a template inducing conformational change in the wild type proteins causing cross-reaction and leading to neurodegeneration. Later, the defective proteins may infect healthy nerve cells, thus neurodegeneration is extended. Growing experimental evidence shows that monomers and aggregates of α-synuclein are secreted via exocytosis from damaged nerve cells and taken up via endocytosis by healthy nerve cells furnishing evidence for the prion-like role of α-synuclein.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Miklya, I., Pencz, N., Hafenscher, F., & Goltl, P. (2014). [The role of alpha-synuclein in Parkinson's disease]. <em>PubMed</em>. https://openalex.org/W2417738638
Vancouver
Miklya I, Pencz N, Hafenscher F, Goltl P. [The role of alpha-synuclein in Parkinson's disease]. PubMed. 2014.
BibTeX
@unpublished{ildik2014Therol,
title = {[The role of alpha-synuclein in Parkinson's disease].},
author = {Ildikó Miklya and N Pencz and Florencia Hafenscher and P Goltl},
journal = {PubMed},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Handbook of clinical neurology 2022
Preprint · OA
T cells, α-synuclein and Parkinson disease
The Journal of Experimental Medicine 1999
Open access · OA
Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood
Frontiers in Immunology 2019
Open access · CC-BY
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
The EMBO Journal 2013
Open access · CC-BY
Endonuclease G mediates α‐synuclein cytotoxicity during Parkinson's disease
BioMed Research International 2015
Open access · CC-BY
Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011
Open access · OA